Rheumatoid arthritis

Rheumatological disease activity and treatments influence risk of death from COVID-19

Level of disease activity and the use of certain medications are associated with the risk of death from COVID-19 among patients with rheumatic diseases, according to an analysis from the Global Rheumatology Alliance physician-reported registry.  “There is a lack of robust data to inform our understanding of outcomes following SARS-CoV-2 infection in patients with inflammatory ...

Already a member?

Login to keep reading.

© 2021 the limbic